Rationale Alcohol addiction is a major psychiatric disease, and yet, the underlying molecular adaptations in the brain remain unclear. Recent evidence suggests a functional role for the ras-specific guanine-nucleotide releasing factor 2 (Rasgrf2) in alcoholism. Rasgrf2 −/− mice consume less alcohol and show entirely absent dopamine responses to an alcohol challenge compared to wild types (WT).
Introduction
Alcohol addiction is a major psychiatric disease. The World Health Organisation (WHO) estimates that 4 % of deaths worldwide each year are associated with the harmful use of alcohol (WHO 2011) . Alcohol use develops into addiction in a significant number of people. While significant heritability estimates of alcohol addiction have been identified (Plomin 1990) , underlying specific genetic influences are emerging slowly (Schumann et al. 2011; Stacey et al. 2009 ). In a recent study, we found evidence for a role of the ras-specific guanine-nucleotide releasing factor 2 (RASGRF2) gene in alcoholism (Stacey et al. 2012) . The study reported a genomewide association of RASGRF2 and alcohol consumption in 28,188 individuals.
Rasgrf2 belongs to a family of calcium/calmodulin-associated guanine nucleotide exchange factors (GEFs; Fernández-Medarde Alanna C. Easton, Andrea Rotter, and Anbarasu Lourdusamy contributed equally to the paper.
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and Santos 2011). Rasgrf2 GEF activity promotes GDP/GTP exchange on specific members of the RAS protein family thus leading to the stimulation of mitogen-activated protein kinase/ extracellular signal-regulated kinase (MAPK/ERK) signal transduction pathway and modulation of various intracellular signalling pathways. Although deletion of RASGRF2 has the potential to have a major impact on neuronal signalling pathways, knockout of Rasgrf2 does not interfere with basal development in mice (Fernández-Medarde et al. 2002) .
Evidence suggests that Rasgrf2 acts on pathways which are also implicated in alcoholism. The RAS-MAPK/ERK pathway has been linked to dopamine D1 receptors (Girault et al. 2007; Tian et al. 2004) , and has also been isolated as a binding partner of the dopamine transporter (Maiya et al. 2007 ). These studies report both a pre-and postsynaptic role for Rasgrf2. Bloch-Shilderman et al. (2001) reported a direct role for the MAPK/ERK pathway in neurotransmitter release. Rasgrf2, as a MAPK/ERK activating protein, may therefore be linked to neurotransmitter release. Rasgrf2
−/− (MT) mice were subsequently found to have entirely absent dopamine responses in the nucleus accumbens (NAcc) and caudate putamen (CPu) to an alcohol challenge. This may account for the reduced alcohol intake and alcohol preference of Rasgrf2 −/− mice when compared to their wild type (WT) litter mates (Stacey et al. 2012) . In order to further investigate how Rasgrf2 modifies the acute and subchronic effects of alcohol in the brain, we investigated its control of the noradrenergic (NA) and serotonergic (5-HT) systems. These monoaminergic systems are consistently implicated in the modulation of alcohol's effects on the reward system (Fahlke et al. 2012; Spanagel 2009; Vengeliene et al. 2008 ). Next to DA, NA and 5-HT are important modulatory transmitters which are involved in the acute and subchronic behavioural effects of alcohol (Fahlke et al. 2012; McBride 2010 ) that contribute to behavioural changes associated with binge drinking and addiction (Smith et al. 2008 ). We performed in vivo microdialysis measuring NA and 5-HT levels in the NAcc and CPu after an alcohol challenge in Rasgrf2 −/− mice. We found that the absence of Rasgrf2 significantly reduced NA and 5-HT responses in both brain regions. In order to assess the role of Rasgrf2 in the neuroadaptations to subchronic alcohol exposure, we measured messenger RNA (mRNA) expression of NA receptors and transporter in the brain.
Experimental procedures
All housing and experimental procedures were performed in accordance with the UK Home Office Animals (Experimental Procedures) Act 1986. All efforts were made to minimize animal suffering and to reduce the number of animals used.
Animals
Male wild type (+/+ WT; 31.38±0.53 g) and null mutant (−/− MT; 34.50 ± 1.34 g) Rasgrf2 tm1Esn (Fernández-Medarde et al. 2002) mice were studied. Mice were generated using a gene targeting strategy and subsequently kept on a genetic background of 129/S-J and C57BL/6. Detailed methods are described by Fernández-Medarde et al. (2002) . The method inactivates the Grf2 locus by targeting its CDC25-H catalytic domain, thereby disrupting the guanine nucleotide exchange factor (GEF) activity of Rasgrf2. Animals were individually housed, provided with food and water ad libitum and kept on a 12:12 h light/dark cycle (lights on at 7.00 a.m.). Experiments were performed during the light cycle between 09:00 and 16:00 h, in a pseudorandom order. Room temperature was maintained between 19 and 22°C at a humidity of 55 % (±10 %). Animals were housed in Tecniplast cages (32 cm×16 cm×14 cm), using Litaspen sawdust and nesting materials (Sizzlenest, Datsand, Manchester UK).
Microdialysis surgery
Mice (WT: n=7; MT: n=6) were deeply anaesthetised with an intraperitoneal (i.p.) injection using a mixture of 4.12 ml saline (NaCl), 0.38 ml Ketaset (containing 100 mg/ml ketamine) and 0.5 ml Domitor (containing 1 mg/ml medetomidine hydrochloride) administered at 0.1 ml per 10 g body weight. In addition, 0.01 ml Rimadyl (5 mg/kg Carprofen) analgesia was given s.c. The animal was placed in a Kopf stereotaxic frame. Two guide cannulas were implanted (Microbiotech/se AB, Stockholm, Sweden), one aimed at the CPu (A: +0.5; L: ±2.3; V: −2.4 angle ±10°from midline) and the other aimed at the NAcc (A: +1.2; L: ±1.6; V: −4.3 angle ±10°from midline) using coordinates relative to bregma (Paxinos and Franklin 2003) , and fixed in place using two anchor screws (stainless steel, d=1.4 mm) and dental cement. Reverse anaesthesia was administered to the animals after approximately 45 min using a mixture of 3.9 ml 0.9 % saline (NaCl) and 0.1 ml Antisedan (containing 5 mg/ml atipamezole) at 0.08 ml per 10 g body weight (s.c.). The animals were kept warm and allowed to recover from the anaesthetic. Animals were then returned to their home cages and monitored daily, allowing at least 5 days for complete recovery (Easton et al. 2013 ).
Microdialysis procedure
One week after implantation, two microdialysis probes of a concentric design (membrane lengths, 2 mm for the CPu (MAB 6.14.2.); 1 mm for the NAcc (MAB 6.14.1)) were inserted into the guide cannulae of each animal under a short (3-5 min) isoflurane anaesthesia (O 2 at 1 l/min, isoflurane at 3 % to induce and 2 % to maintain anaesthesia). Both structures are important for different kinds of drug-related behaviours and receive a dense monoaminergic innervation (Belin et al. 2008) . After probe insertion, the animal was placed into the open field (21×21×30 cm) of a Truscan system (Coulbourn Instruments, Allentown, USA). Food and water were given ad libitum and room temperature maintained between 19 and 22°C. The microdialysis probes were connected to a microinfusion pump (CMA 400, Carnegie, Sweden) via a swivel mounted on a balanced arm above the chamber, and were perfused with artificial cerebrospinal fluid (aCSF) (containing Na + 147 mmol, K + 4 mmol, Ca 2+ 2.2 mmol, Cl − 156 mmol, pH 7.4) at room temperature. The flow rate was set to 1.5 μl/min and allowed to stabilise for at least 2 h until a stable baseline with no more than 20 % deviation was obtained. Samples were collected every 20 min into vials containing 2.73 μl of antioxidant (0.1 M perchloric acid and 500 pg dihydroxybenzylamine (DHBA) as internal standard). Three samples taken during the first testing hour of the experiment provide baseline quantities of NA and 5-HT (Pum et al. 2007 (Pum et al. , 2008 ). An injection of alcohol was then administered at 2 g/kg, v inj =10 ml/kg (i.p.). A further ten samples were collected in conjunction with behavioural testing (Easton et al. 2013 ).
HPLC-ED analysis
All samples were analysed using high-performance liquid chromatography with electrochemical detection (HPLC-ED) to measure NA and 5-HT levels in the CPu and NAcc. The column used was an ET 125/2, Nucleosil 120-5, C-18 reversed phase column (Macherey-Nagel, Germany) perfused with a mobile phase composed of 75 mM NaH 2 PO 4 , 4 mM KCl, 20 μM ethylenediamine tetraacetic acid (EDTA), 1.5 mM sodium dodecyl sulfate, 100 μl/l diethylamine, 12 % methanol and 12 % acetonitrile adjusted to pH 6.0 using phosphoric acid (Amato et al. 2011; Pum et al. 2008) . The electrochemical detector (Intro, Antec, The Netherlands) was set at 500 mV versus an in situ Ag/AgCl (ISAAC) reference electrode (Antec, Leyden, The Netherlands) at 30°C. The detection limit of the assay was 0.1 pg with a signal-noise ratio of 2:1.
Behavioural analysis
Locomotor activity was measured in conjunction with in vivo microdialysis experiments. Horizontal locomotor activity was automatically calculated in arbitrary units by the Truscan system in 20-min intervals over 200 min.
Histological analysis
Once microdialysis experiments were completed, animals were sacrificed by cervical dislocation and the localization of microdialysis probes was verified. Only animals with probe placement within the CPu and the NAcc were considered for data analysis.
Subchronic alcohol treatment
In order to investigate the link between Rasgrf2 and the NAand 5-HT systems in the brain and the neuroadaptations following subchronic alcohol treatment, we measured mRNA expression in the brain. Single-housed Rasgrf2 −/− (n=8-9/ group) and WT mice (n=8-9/group) received a daily i.p. injection with either alcohol (3.5 g/kg) or saline for 7 days. In this experiment, we used a higher alcohol dose, which may have acute sedating effects (Easton et al. 2013) , to uncover also more subtle genotype differences in the NA system. After each injection, animals were placed back to their home cages. One hundred and twenty minutes after the last injection, animals were sacrificed by cervical dislocation and the brain was removed and immediately cooled on dry ice. Tissue was kept at −80°C until further analysis.
Tissue preparation
The frozen brains were placed on a cold dissecting surface and hemispheres were separated by cutting in the sagittal plane. After removing the cerebellum and frontal cortex, the dorsal and ventral striatum (including the NAcc) and the hippocampus were dissected. Total RNA was extracted from brain using a modified QIAGEN-protocol as follows: a phenol-extraction in QIAzol (QIAGEN) was followed by column-purification with RNeasy mini kit (QIAGEN), including DNase digestion according to the manufacturers protocol. Complementary DNA (cDNA) was synthesized using iScript cDNA synthesis kit (Bio-Rad, Munich/Germany) following manufacturer's instructions.
RNA amplification and microarray hybridisation
We generated biotinylated, amplified RNA from total RNA by using the Illumina® TotalPrep™ RNA amplification kit (Applied Biosystems/Ambion, Austin, TX, USA) following the manufacturer's instructions. Briefly, 500 ng of total RNA was converted into first-strand cDNA. After second-strand cDNA synthesis and cDNA purification, in vitro transcription overnight generated biotinylated amplified RNA, which was purified and quantified using a Qubit® 2.0 fluorometer (Invitrogen Ltd., Paisley, UK). The size distributions of amplified RNA were made by running each sample on the Bioanalyzer (Agilent Technologies UK Ltd., Wokingham, UK) using the Eukaryotic mRNA Assay with smear analysis (De Souza Silva et al. 2013 ).
Gene expression profiling
In order to investigate whether expression of NA-and 5-HT genes is influenced by Rasgrf2, we measured genome-wide expression profiles in the ventral striatum of Rasgrf2 −/− and WT mice after saline treatment. Gene expression profiling was performed using the Illumina Mouse WG-6 v2.0 expression BeadChip that contains 45,281 probes (Illumina Inc., San Diego, CA, USA). Amplified RNA (1.5 μg) was used for hybridization of each array. The hybridization, washing and scanning were performed according to the manufacturer's instructions.
RT-PCR analysis
Genome-wide gene expression analysis in the ventral striatum identified a relationship between Rasgrf2 and α2 adrenoceptor mRNA expression, but not with expression of genes in the 5-HT pathway (Supplementary Table 1) . Accordingly, we focused the analysis of alcohol-induced brain-wide gene expression on NA pathway-related genes only. Quantitative RT-PCR was performed using SYBR Green I Master Mix buffer (Applied Biosystems), and reactions were run on an iCycler (Roche) using a three-step standard protocol. The annealing temperature was optimized for all primer pairs and ranged from 55 to 65°C. PCR products were visualized on standard 2 % agarose gels with ethidium bromide to eliminate the possibility of having amplified genomic DNA. β-actin was used as internal standard, and CT values were calculated from differences between β-actin and the target genes. All experiments were repeated at least three times and the mean value used for further analysis.
The following primer pairs were used: Β-actin-F: CTGTATTCCCCTCCATCGTG Β-actin-R: GAAGATCTGGCACCACACCT NAT-F: TCAACTTCAAGCCGCTTACC NAT-R: GGTTCAGATAGCCAGCCAGT Adra2a-F: GTTCTGGCTGAGAGGG Adra2a-R: AAGGAAGGGGGTGTGGAG Adra2b-F: GCAGAGGTCTCGGAGCTAA Adra2b-R: GCCTCTCCGACAGAAGATA Adra1b-F: GAAAAGAAAGCAGCCAAA Adra1b-R: CTGGAGCACGGGTAGATGAT
Statistical analysis
Behaviour and neurochemistry All graphical output data were expressed as a mean ± SEM. Baseline behavioural and neurochemical data were analysed using pre-planned t test comparisons to determine the differences seen between genotype groups prior to alcohol administration based on the average of the three baseline samples. Data was analysed using planned t test comparisons. Alcohol-induced locomotor activation and neurochemical data was expressed as a percentage of the mean of the three baseline samples which were taken as 100 %. Behavioural and neurochemical data were compared using two-way ANOVAs for factor genotype (3) and time (13 
Results
Rasgrf2 deficiency is associated with increased locomotion and basal noradrenaline activity
Basal activity of Rasgrf2 −/− and WT mice, expressed as the mean of the three 20-min baseline samples, was significantly different (Fig. 1a) . Rasgrf2 −/− mice were found to have a higher level of locomotor activity than WT mice (t=2.71, df=34, p=0.01). Rasgrf2 −/− mice were also found to have increased basal NA levels (mean of the three baseline samples) in the NAcc (t=4.32, df=37, p<0.001) and the CPu (t= 5.56, df=37, p<0.0001), compared to WT mice (Fig. 2a) . Rasgrf2 −/− mice showed enhanced basal 5-HT levels in the NAcc (t=−4.87, df=37, p<0.0001) but decreased levels the CPu (t=3.78, df=38, p<0.0006), compared to WT mice (Fig. 3a) .
Rasgrf2 contributes to noradrenergic and serotonergic activation and behavioral activity after acute alcohol treatment Behaviour analysis of normalized data revealed genotype differences in alcohol-induced locomotor activation. A twoway ANOVA revealed a significant effect of time (F 12,108 = 2.53, p=0.006), but no overall effect of genotype (F 1,9 =3.00, p=0.12) or interaction (F 12,108 =0.88, p=0.56). Pre-planned comparisons showed a somewhat delayed increase in locomotion 160 min (p=0.03) and 200 min (p=0.0032) after alcohol injection versus baseline in the WT mice (Fig. 1b) .
No increase in locomotion was observed in the Rasgrf2
−/− mice (p>0.05; for raw data, see Supplementary Table 2) . NA levels in the NAcc steadily increased after an alcohol challenge (Fig. 2b) . The analysis showed a significant time effect (F 12,120 =7.38, p<0.001), but no genotype, or genotype x time interaction (p>0.05). A within group analysis using preplanned pairwise comparisons suggested that, compared to basal levels, WT mice show a significantly increased level of NA at 100 min (p<0.03), 120 min (p=0.05) and 200 min (p=0.05) after an acute injection of alcohol. Rasgrf2 −/− mice show no significant differences in NA levels compared to baseline after alcohol treatment (p>0.05).
The NA response to alcohol in the CPu shows a similar profile to that seen in the NAcc. Two-way ANOVA revealed a significant time effect (F 12,120 =5.03, p<0.001; Fig. 2c ), but no genotype effect or genotype x time interaction (p>0.05). Within group analysis confirmed significantly increased NA levels in the WT mice at 100 min (p=0.01) and 120 min (p<0.001) compared to baseline, after acute alcohol administration. Rasgrf2
−/− did not significantly differ from basal transmitter levels after alcohol treatment (p>0.05).
Alcohol treatment increased extracellular 5-HT levels in the NAcc of WT mice, but had no effect in Rasgrf2 −/− mice (Fig. 3b ). Analysis showed a significant effect of genotype (F 1,9 =17.41, p=0.002), and time (F 12,108 =2.02, p=0.03), but no genotype x time interaction (p>0.05). A within group analysis using pre-planned pairwise comparisons suggested that, compared to basal levels, WT mice show a significantly increased 5-HT level 20 min (p=0.03) after an acute alcohol injection. Rasgrf2 −/− did not significantly differ from basal 5-HT levels in the Nacc after alcohol treatment (p>0.05). A similar 5-HT response was observed in the CPu. Alcohol treatment increased extracellular 5-HT levels in WT, but not in Rasgrf2 −/− mice (Fig. 3c ). Analysis showed a significant genotype effect (F 1,10 =11.81, p=0.006), but no time effect (p>0.05). However, there was a significant genotype x time interaction (F 12,120 =1.91, p=0.04). A within group analysis using pre-planned pairwise comparisons suggested that, compared to basal levels, WT mice showed a significantly increased 5-HT level 20 min (p=0.02), 60 min (p=0.05) and 120 min (p = 0.02) after an acute injection of alcohol. Rasgrf2 −/− did not significantly differ from basal 5-HT levels in the CPu after alcohol treatment (p>0.05).
Rasgrf2 and α2 adrenoceptor co-expression in the ventral striatum
A co-expression analysis showed that there was a high correlation between Rasgrf2 and α2 adrenoceptor (Adr2a) mRNA expression in the ventral striatum in WT animals (R=0.9277, p=0.0125). No other correlation of Rasgrf2 with NA-or 5-HT pathway-related gene expression reached significance (Table 1  and Supplementary Table 1) . These findings suggest a link between Rasgrf2 and NA-, but not 5-HT systems at the level of the ventral striatum.
Rasgrf2 controls noradrenergic gene expression in the brain after alcohol treatment
In order to further explore the role of Rasgrf2 in the neuroadaptations to chronic alcohol exposure, we investigated the expression of NA pathway-related genes in response to alcohol in Rasgrf2 −/− and WT mice.
β1-adrenoceptor There was no difference in β1-adrenoceptor mRNA between Rasgrf2 −/− and WT after saline treatment (Fig. 4a) . Subchronic alcohol treatment reduced mRNA expression significantly in the WT, but not in the Rasgrf2 −/− mice ( Fig. 4b p=0.012; dorsal striatum: p=0.008; hippocampus: 0.014; cerebellum: p=0.0008).
β2-adrenoceptor There was no difference in β2-adrenoceptor mRNA expression between Rasgrf2 −/− and WT mice after saline treatment (Fig. 4c ). Subchronic alcohol treatment had no effect on β2-adrenoceptor mRNA expression in the WT, but reduced mRNA expression in the Rasgrf2 −/− mice ( Fig. 4d; Noradrenaline transporter NAT mRNA expression did not differ between Rasgrf2 −/− and WT mice, neither after saline nor after subchronic alcohol administration ( Fig. 4g, h 
Discussion
The monoaminergic systems have consistently been implicated in the modulation of the effects of alcohol on the reward system (Fahlke et al. 2012; Spanagel 2009; Vengeliene et al. 2008) . NA and 5-HT are involved in the modulation of alcohol's behavioural and neurochemical effects (Fahlke et al. 2012; McBride 2010) and both systems have been implicated in long-term adaptive changes induced by alcohol consumption (Berggren et al. 2002; Fahlke et al. 1999; Nutt and Glue 1988; Smith et al. 2008 ). Rasgrf2 has recently been shown to mediate the dopaminergic responses to alcohol in the NAcc and CPu by Fig. 2 The role of Rasgrf2 in alcohol effects on noradrenaline activity. a Noradrenaline basal levels in the nucleus accumbens (NAcc) and caudate putamen (CPu) prior to alcohol treatment (***p<0.001, t test). b Extracellular noradrenaline levels after acute alcohol (2 g/kg, i.p.) treatment in the NAcc and c CPu (*p≤0.05, **p≤0.01, ***p≤0.001 vs. controlling sensitivity of dopaminergic neurons in the ventral tegmental area (Stacey et al. 2012) . In this study, WT animals showed an alcohol-induced increase of extracellular NA and 5-HT levels in both the NAcc and the CPu. A delayed increase in locomotor activity was also apparent. Mice lacking Rasgrf2 showed an enhanced baseline locomotor activity and enhanced basal NA levels in the NAcc and CPu. 5-HT baseline levels were enhanced in the NAcc, but attenuated in the CPu. These findings suggest that a lack of Rasgrf2 may cause hyper-arousal in knockout mice. Interestingly, an alcohol challenge had no effect on locomotor activation and NA responses in the Rasgrf2 −/− mice compared to WT. The 5-HT response, in addition, was completely lacking in Rasgrf2 −/− mice. These findings suggest that the locomotor stimulating effects of a medium dose of alcohol may depend on Rasgrf2 integrity and on downstream NA and 5-HT activation. Given that basal locomotion and monoamine levels were already enhanced, the lack of an additional activation may be due to a ceiling effect in the activity of these neurotransmitter systems. Present data also suggest that Rasgrf2 influences basal NA and 5-HT activity. These findings are largely in line with a previously reported role of Rasgrf2 in the control of basal and alcohol-induced dopaminergic activity (Stacey et al. 2012) . It should be noted that the time course of locomotor activation did not parallel that of the 5-HT response, but rather followed the NA increase. In order to experience the acute reinforcing effects of alcohol, certain neurotransmitter systems in the reward centres of the brain are recruited (Koob et al. 1998; McBride 2010) . NA is a modulatory transmitter which is involved in the acute and Fig. 3 The role of Rasgrf2 in alcohol effects on serotonin activity. a Serotonin basal levels in the nucleus accumbens (NAcc) and caudate putamen (CPu) prior to alcohol treatment (***p<0.001, t test). b Extracellular serotonin levels after acute alcohol (2 g/kg, i.p.) treatment in the NAcc and c CPu (*p<0.05 vs. baseline) 
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*** ** *** *** subchronic behavioural effects of alcohol (Fahlke et al. 2012) , and may account for the altered locomotor effects seen in these mice. Ethanol consumption significantly decreases the rate of NA turnover in specific brain areas such as the NAcc, PFC and amygdala, and such changes are thought to contribute to behavioural changes associated with binge drinking (Smith et al. 2008) . Although a crucial role of 5-HT in the behavioural effects of alcohol is well supported (McBride 2010) , present data suggest that the observed 5-HT increase may be less important than NA increases for locomotor activation in the absence of a DA response (Stacey et al. 2012) . One possible explanation for attenuated behavioural and neurochemical effects of alcohol in the Rasgrf2 −/− mice could have been changes in alcohol bioavailability. We measured alcohol blood levels at various intervals after administration previously and did not find any differences between genotypes (Stacy et al. 2012 ). This suggests that behavioural and neurochemical effects are not due to different bioavailability of alcohol. There was also a small difference in the body weight of the animals, in that Rasgrf2 −/− mice were heavier than WT mice. However, in the light of a preserved alcohol bioavailability, it appears unlikely that this may account for the strongly reduced behavioural and neurochemical effects of alcohol in the Rasgrf2 −/− mice.
An analysis of mRNA co-expression of Rasgrf2 and important components of the NA-and 5-HT systems showed that in the ventral striatum only the α2 adrenoceptor mRNA expression correlated highly with Rasgrf2. This suggests a strong link between Rasgrf2 and the NA system in an alcoholreinforcement related brain area. Subsequent analysis, which sought to compare expression between different brain areas, focused on NA receptors and the NAT. After subchronic alcohol treatment, β1 adrenoceptor levels were elevated in WT mice in all brain areas tested, but there were no changes in β2 and α2 adrenoceptor levels, or in expression levels of NAT. Following subchronic alcohol exposure, Rasgrf2 −/− mice showed no adaptation of β1 adrenoceptors, but did differentially express β2 adrenoceptors in the ventral striatum, hippocampus and cerebellum, and α2 adrenoceptors in all brain areas tested at a reduced level. Like WT mice, Rasgrf2 −/− mice showed no change in NAT expression. A reduction in α2 adrenoceptor function has been reported in alcohol withdrawal (Balldin et al. 1992; Fahlke et al. 1999; Nutt and Glue 1988) . α2C adrenoceptors are known to be involved in behaviour modulation and α2A adrenoceptors have a role in presynaptic feedback inhibition of NA release and in sedation (Brede et al. 2004) . In humans, α2-agonists are used as sedative, hypnotic, analgesic agents. These effects are selectively mediated by the α2A adrenoceptor subtype (Lakhlani et al. 1997) . α2A and α2C adrenoceptors are known to complement one another to integrate brain function and behaviour (Brede et al. 2004 ). Together, these data suggest that the noradrenergic system can alter behavioural responses to alcohol and that Rasgrf2 may be a key mediator in this process. Present data suggest that Rasgrf2 regulates the adaptation of adrenoceptors to subchronic alcohol administration. Rasgrf2 appears to be essential for β1 adaptation, whilst preventing β2 and α2 adaptations. This might contribute to the diminished alcohol preference seen in the Rasgrf2 −/− mice (Stacey et al. 2012) . Increases in NA have been shown to result in the downregulation of the β1 adrenoceptor in cardiac tissue (Dong et al. 1999; Thomas and Marks 1978) . This may account for the adaptations we have observed in response to subchronic alcohol exposure in the WT mice. Since the Rasgrf2 −/− NA response is reduced acutely, this may explain the absence of β1 adaptation in these mice. In response to repeated alcohol treatments, WT mice do not typically alter their β2 and α2 adrenoceptor levels. However, Rasgrf2
mice showed a distinct downregulation of these receptors. NA signalling through the α2 adrenoceptor is known to be involved in the negative feedback control mechanism in neuronal synapses, thus, regulating NA release from the presynaptic nerve terminals of the brain (Brede et al. 2004; Schwartz 1997; Starke 2001) . α2A adrenoceptors can also acts as heteroreceptors in the brain and have been shown to inhibit DA in the basal ganglia (Bucheler et al. 2002) and 5-HT release in the hippocampus and cortex (Scheibner et al. 2001) . The downregulation of α2 receptors could therefore have some bearing on the 5-HT response here and DA levels previously reported (Stacey et al. 2012) . Present data suggest that Rasgrf2 is capable of mediating the amount of NA released to the synaptic cleft. Rasgrf2 activates the Ras protein and thereby stimulates the MAPK/ERK signalling pathway. Adrenoceptors have been shown to differentially alter the activation of the MAPK/ERK pathway. Williams et al. (1998) demonstrated that stimulation of α1A and β1 adrenoceptors by NA resulted in substantial ERK activation. Indeed, α1A activation stimulated all three MAPK pathways and cell differentiation. Stimulation of α2 adrenoceptors did not appear to alter ERK activity (Williams et al. 1998 ). This, however, seems to contradict earlier studies which suggested that α2 adrenoceptors activated the MAPK/ERK pathway (Alblas et al. 1993; Howe and Marshall 1993; Winitz et al. 1993) .
A limitation of the present study is that changes in mRNA expression were only measured after repeated 7 day subchronic alcohol versus saline treatment. Thus, we cannot definitively determine at which point expression levels changed during Fig. 4 The role of Rasgrf2 in alcohol-induced changes in mRNA expression of a, b β1-adrenoceptor, c, d β2-adrenoceptor, e, f α2-adrenoceptor and g, h the noradrenaline transporter (NAT) in the brain of Rasgrf2
−/− and wild type mice. Higher deltaCT values represent lower mRNA expression rate (mean ± SEM; FC frontal cortex, VStr ventral striatum, DStr dorsal striatum, Hipp hippocampus, Cer cerebellum; * p<0.05, **p<0.01, ***p<0.001) the 7-day treatment. Neither can we say how constant they would be when alcohol exposure escalates and becomes chronic as is the case in addiction. Since microdialysis was performed after acute treatment only, we cannot rule out the possibility of chronic adaptations of the neurochemical responses (Berggren et al. 2002) , which may result from changes in adrenoceptor expression levels. In addition, not all adrenoceptors were measured in the present study, thus it is not possible to know the extent to which these might play a role in the NA response to subchronic alcohol exposure. Nor do our results rule out NAT expression changes in general, but only in target area neurons. For example, there is a chance that NAT expression might be affected in the locus coeruleus neurons by Rasgrf2 (Zippel et al. 1997) .
In summary, the current study suggests an important role of Rasgrf2 in the NA system's response to alcohol. Rasgrf2 appears to mediate the presence of NA and 5-HT in the synaptic cleft at both basal level and after acute alcohol exposure. Rasgrf2 and the NA system are specifically linked by co-expression of Rasgrf2 with α2 adrenoceptor mRNA at basal conditions. After subchronic alcohol exposure, the NA system is modified, and Rasgrf2 regulates alterations in expression levels of adrenoceptor mRNA. Rasgrf2 may be a mechanism by which the NA system is prevented from adapting to subchronic alcohol, which could in turn influence vulnerability to the effects of repeated alcohol exposure.
